Dr. Sara McMenamin of University of California, San Diego, will present results from her SHARE-funded research at the 10th Annual Conference on the Science of Dissemination and Implementation in Health.
Presentation At-a-Glance
Dr. McMenamin’s SHARE research examined state progress in implementing the ACA’s four provisions regarding Medicaid coverage for smoking cessation treatments. These provisions address: (1) coverage for pregnant women; (2) coverage for all enrollees through an increased federal match incentive; (3) coverage for all enrollees through Medicaid formulary requirements; and (4) coverage for Medicaid expansion enrollees.
From January through June 2017, Dr. McMenamin and her team studied Medicaid programs in all 50 states and the District of Columbia and found that 46 Medicaid programs had increased coverage for smoking cessation treatments by executing one or more of the four provisions. The most commonly implemented provision was coverage of comprehensive treatments for pregnant women without cost-sharing, which 27 Medicaid programs had in place. In all, only 11 state programs had implemented all four smoking cessation treatment provisions in the ACA.
Access the full presentation abstract.
Logistics
The D&I Conference is co-hosted by the National Institutes of Health and AcademyHealth and will take place December 4th through 6th in Arlington, VA.
Dr. McMenamin’s presentation is on December 4th at 2:50 p.m. at the Crystal Gateway Marriott, Salon B.